The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global isothermal nucleic acid amplification technology market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The isothermal nucleic acid amplification technology (INAAT) is used in the field of molecular biology and recombinant DNA technologies for detecting and analyzing nucleic acids. This technique is commonly used for DNA, RNA, cells, proteins, small molecules and ions to ensure the rapid, sensitive and accurate diagnosis of infectious, genetic and inherited diseases. The amplicons generated from this technique are used for producing versatile nucleic acid nanomaterials that are widely utilized in biomedicine, bioimaging and biosensing. They are also used for the detection of various infectious diseases, such as (HIV), tuberculosis, influenza, hepatitis A and B, chlamydia and gonorrhea (CT/NG).
One of the leading trends in the global market is the ongoing development of INAAT for the detection of the coronavirus disease (COVID-19), as it can be conducted at room temperature, without the need for specialized laboratory equipment. Furthermore, the increasing prevalence of cancer and other chronic medical ailments, along with the rising demand for efficient diagnosis and treatment alternatives, is also providing a boost to the market growth. In line with this, the widespread adoption of Loop-mediated Isothermal Amplification (LAMP) tests that are used for the amplification of both DNA and RNA, along with the identification of genetically modified organisms (GMOs) is driving the product demand further. Additionally, various technological advancements, such as the development of Strand Displacement Amplification (SDA), Single Primer Isothermal Amplification (SPIA) and Recombinase Polymerase Amplification (RPA), is acting as another growth-inducing factor. Other factors, including the rising geriatric population across the globe, coupled with extensive research and development (R&D) activities in the field of microbiology and significant growth in the healthcare infrastructure, are projected to drive the market further.
Breakup by Product:
Breakup by Technology:
Breakup by Application:
Breakup by End-User:
Breakup by Region:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, bioMérieux, BD (Becton, Dickinson and Company), Eiken Chemical Co. Ltd., Hologic Inc., Meridian Bioscience Inc., OptiGene Limited, Thermo Fisher Scientific Inc., Tecan Trading AG, Ustar Biotechnologies Ltd., etc.
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at